{"id":40371,"date":"2025-11-12T13:21:56","date_gmt":"2025-11-12T10:21:56","guid":{"rendered":"https:\/\/massivebio.com\/?p=40371"},"modified":"2025-11-14T10:42:23","modified_gmt":"2025-11-14T07:42:23","slug":"massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey","status":"publish","type":"post","link":"https:\/\/massivebio.com\/massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey\/","title":{"rendered":"Massive Bio Announces Reticulum Nexus &#8211; an AI-Driven Multi Agent Platform orchestrating the end-to-end patient journey"},"content":{"rendered":"<section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>FOR IMMEDIATE RELEASE<\/strong><\/p>\n<p><strong>Massive Bio Unveils Reticulum Nexus, the Patient\u2011Centric, Multi\u2011Agent Platform Orchestrating the Full Oncology Journey<\/strong><\/p>\n<p><strong>New <em>Radiant Core<\/em> control plane and <em>SYNERGY\u2011AI OS<\/em> power real\u2011time, end\u2011to\u2011end operations from first outreach to last\u2011mile enrollment<\/strong><\/p>\n<p><strong>Berlin, Germany &#8211;<\/strong><strong>ESMO AI &amp; Digital Oncology Congress 2025 &#8211; November 12, 2025<\/strong> &#8211; Massive Bio today announced <strong>Reticulum Nexus<\/strong>, a patient\u2011centric, multi\u2011agent platform that connects and coordinates the entire oncology journey, from initial outreach and data collection to deep analytics, site activation, and enrollment. The platform is coordinated by <strong>Radiant Core<\/strong>, Massive Bio\u2019s new control plane for knowledge, quality, and compliance, and is powered by <strong>SYNERGY\u2011AI OS<\/strong>.<\/p>\n<p>The announcement follows a year of scale and validation: the <a href=\"https:\/\/www.cancer.org\/cancer\/managing-cancer\/making-treatment-decisions\/clinical-trials\/acs-acts.html\" target=\"_blank\" rel=\"noopener\">national rollout of ACS ACTS <\/a>highlighted Massive Bio\u2019s patient\u2011first approach; the company\u2019s <a href=\"https:\/\/massivebio.com\/massive-bio-recognized-by-white-house-cancer-moonshot\/\">AI prescreening hubs were recognized by Cancer Moonshot<\/a>; and <a href=\"https:\/\/www.precisioncancerconsortium.com\/revolutionizing-cancer-trial-matching-pcc-and-massive-bios-ai-driven-multi-sponsor-study-delivers-promising-results\/\" target=\"_blank\" rel=\"noopener\">partners such as PCC<\/a>, alongside other major stakeholders, expanded deployment across networks and populations.<\/p>\n<p>\u201cMost systems optimize a single site. <strong>Reticulum Nexus<\/strong> optimizes <strong>the patient and the whole network<\/strong>, patients, providers, sites, sponsors, and communities, so that every step is coordinated,\u201d said <a href=\"https:\/\/www.linkedin.com\/in\/selinkurnaz\/\" target=\"_blank\" rel=\"noopener\"><strong>Selin Kurnaz, PhD, Co\u2011founder &amp; CEO of Massive Bio<\/strong><\/a>. \u201cWhat once took ~200 hours of human effort now runs as an <strong>agentic, human\u2011in\u2011the\u2011loop workflow<\/strong>. The result is speed with empathy: more patients reached, faster answers, and auditable decisions.\u201d<\/p>\n<p>\u201c<a href=\"https:\/\/ai.nejm.org\/doi\/pdf\/10.1056\/AIp2500005?download=true\" target=\"_blank\" rel=\"noopener\">Moravec\u2019s Paradox<\/a> teaches us that machines excel at the repetitive while humans excel at the contextual,\u201d said <a href=\"https:\/\/www.linkedin.com\/in\/arturoloaizabonillla\/\" target=\"_blank\" rel=\"noopener\"><strong>Arturo Loaiza\u2011Bonilla, MD, Co\u2011founder and Chief Medical AI Officer<\/strong><\/a>. \u201cWith <strong>Reticulum Nexus<\/strong>, multi\u2011agent, contextual AI performs the operational grind so clinicians and coordinators can focus on the human parts of care. We\u2019re already supporting thousands of patients with <strong>Dr. Arturo AI<\/strong>, now we can responsibly scale to millions.\u201d<\/p>\n<p>\u201c<strong>Radiant Core<\/strong> is the control plane that makes agentic AI dependable in the real world,\u201d said <a href=\"https:\/\/www.linkedin.com\/in\/cagatayculcuoglu\/\" target=\"_blank\" rel=\"noopener\"><strong>Cagatay Culcuoglu, Co\u2011founder; CTO &amp; COO<\/strong><\/a>. \u201cIt supervises knowledge, quality, and compliance across the entire workflow, routing tasks, sharing context, and enforcing policy, while <strong>SYNERGY\u2011AI OS<\/strong> ensures agents collaborate safely and efficiently across Patient Connect, Clinical Network Apps, and partner systems. Interoperability, auditability, and performance are built in from day one.\u201d<\/p>\n<p><strong>What\u2019s new in Reticulum Nexus<\/strong><\/p>\n<ul>\n<li><strong>Radiant Core (control plane).<\/strong><br \/>\nA central knowledge, quality, and compliance layer that supervises agents end\u2011to\u2011end. Radiant Core monitors data accuracy, explains decisions, enforces policy, and enables auditable, human\u2011in\u2011the\u2011loop interventions.<\/li>\n<li><strong>Powered by SYNERGY\u2011AI OS.<\/strong><br \/>\nAn operating system for multi\u2011agent collaboration that routes tasks, shares context, and composes workflows across <strong>Patient Connect<\/strong>, <strong>Clinical Network Apps<\/strong>, and partner systems.<\/li>\n<li><strong>Interoperable by design.<\/strong><br \/>\nNative <strong>FHIR\/mCODE<\/strong> integration and open interfaces connect EHRs, labs, sponsors, CROs, community clinics, and registries. The platform is engineered to operate in heavily regulated environments (e.g., <strong>GDPR<\/strong>) with privacy\u2011by\u2011design governance.<\/li>\n<li><strong>Agentic operations across the full journey.<\/strong><br \/>\nFrom <strong>Patient Intake Agents<\/strong> (lead generation, consent, MR collection) to <strong>Data Processors<\/strong> (abstraction\/parameterization) and domain\u2011specific agents (<strong>clinical matching<\/strong>, <strong>commercial intelligence<\/strong>, <strong>RWD analytics<\/strong>), each agent is orchestrated by Radiant Core to deliver reliable, repeatable outcomes.<\/li>\n<li><strong>Causal ML for proactive action.<\/strong><br \/>\nPredictive models identify where outreach, resources, or site activation will have the greatest effect, turning insight into <strong>just\u2011in\u2011time<\/strong><\/li>\n<li><strong>DCT\u2011ready last mile.<\/strong><br \/>\nDecentralized and hybrid trial capabilities, including <strong>home health logistics<\/strong>, <strong>eConsent<\/strong>, and <strong>remote monitoring<\/strong>, are natively supported to expand access and equity.<\/li>\n<li><strong>Designed to resolve the \u201cClinical Trial Enrollment Paradox.\u201d<\/strong><br \/>\nBy aligning patients, providers, and sites with sponsors and payers, in one operating fabric, <strong>Reticulum Nexus<\/strong> unlocks enrollment at scale without overwhelming frontline teams.<\/li>\n<\/ul>\n<p><strong>Products and modules at launch<\/strong><\/p>\n<ul>\n<li><strong>Patient Connect &amp; Clinical Network Apps<\/strong> &#8211; Mobile\u2011to\u2011EHR pathways that meet people where they are (patients, caregivers, community oncology) while streamlining provider workflows.<\/li>\n<li><strong>Clinical Trial Enabler<\/strong> &#8211; Real\u2011time eligibility surfacing; transparent, clinician\u2011readable rationales; and last\u2011mile enrollment logistics.<\/li>\n<li><strong>Commercial Intelligence &amp; RWD Explorer<\/strong> &#8211; Responsible insights for medical and commercial teams to understand unmet need, feasibility, and outcomes, within governance guardrails.<\/li>\n<li><strong>Dr. Arturo AI (multi\u2011agent assistant)<\/strong> &#8211; Patient\u2011facing and clinician\u2011supporting agents that scale navigation, education, and next\u2011best\u2011action, always with human oversight.<\/li>\n<\/ul>\n<p><strong>Commitment to openness and equity<\/strong><\/p>\n<p>Massive Bio reaffirmed its alignment with the <a href=\"https:\/\/www.cms.gov\/priorities\/health-technology-ecosystem\/overview\" target=\"_blank\" rel=\"noopener\">CMS pledge<\/a> for access and interoperability. <strong>Reticulum Nexus<\/strong> is open to <strong>sponsors, CROs, sites, providers, and community clinics<\/strong> seeking to expand trial access and outcomes through <strong>collaborative intelligence<\/strong>, not just site\u2011centric optimization.<\/p>\n<p><strong>Availability<\/strong><\/p>\n<p><strong>Reticulum Nexus<\/strong>, coordinated by <strong>Radiant Core<\/strong> and powered by <strong>SYNERGY\u2011AI OS<\/strong>, is available <strong>to select partners beginning today<\/strong>, with additional programs opening on a rolling basis. Organizations interested in early access, DCT pilots, or just\u2011in\u2011time activation across networks can contact Massive Bio for partnership details.<\/p>\n<p><strong>About Massive Bio<\/strong>:<\/p>\n<p>Massive Bio, co-founded by\u00a0<a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fselinkurnaz%2F&amp;esheet=54341044&amp;newsitemid=20251017843393&amp;lan=en-US&amp;anchor=Selin+Kurnaz&amp;index=8&amp;md5=d1d63aa2267160f6dfe53bf8150ec40d\" target=\"_blank\" rel=\"noopener\"><strong>Selin Kurnaz<\/strong><\/a>,\u00a0<a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Farturoloaizabonillla%2F&amp;esheet=54341044&amp;newsitemid=20251017843393&amp;lan=en-US&amp;anchor=Arturo+Loaiza-Bonilla&amp;index=9&amp;md5=50d9552e6a62226abe454cd439191a95\" target=\"_blank\" rel=\"noopener\"><strong>Arturo Loaiza-Bonilla<\/strong><\/a>, and\u00a0<a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fcagatayculcuoglu%2F&amp;esheet=54341044&amp;newsitemid=20251017843393&amp;lan=en-US&amp;anchor=%26%23199%3Ba%26%23287%3Batay+%26%23199%3Bulcuo%26%23287%3Blu&amp;index=10&amp;md5=2a387a0235eea52530e73cd4955cded1\" target=\"_blank\" rel=\"noopener\"><strong>\u00c7a\u011fatay \u00c7ulcuo\u011flu<\/strong><\/a>, transforms the pharmaceutical value chain with AI-driven solutions. As an AI-enabled real-world data company, it streamlines the patient\u2019s journey, enhances access to advanced treatment options, and optimizes clinical trials. Massive Bio collaborates with pharmaceutical companies, research organizations, and healthcare institutions worldwide. A founding member of the CancerX public-private partnership and participant in the Cancer Moonshot White House initiative, the company has received recognition from the National Cancer Institute and operates across 17 countries with a global team of over 100 employees. For more information, visit\u00a0<a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.massivebio.com%2F&amp;esheet=54341044&amp;newsitemid=20251017843393&amp;lan=en-US&amp;anchor=www.massivebio.com&amp;index=11&amp;md5=8080a330a75b5f1c4ec8b46a3609fc13\"><strong>www.massivebio.com<\/strong><\/a>.<\/p>\n<p><strong>Contacts<\/strong><\/p>\n<p><strong>Media Contacts:<\/strong><br \/>\nMassive Bio<br \/>\nMert Turkkan<br \/>\nMarketing Director<br \/>\n<a href=\"mailto:mturkkan@massivebio.com\"><strong>mturkkan@massivebio.com<\/strong><\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"FOR IMMEDIATE RELEASE Massive Bio Unveils Reticulum Nexus, the Patient\u2011Centric, Multi\u2011Agent Platform Orchestrating the Full Oncology Journey New Radiant Core control plane and SYNERGY\u2011AI OS power real\u2011time, end\u2011to\u2011end operations from first outreach to last\u2011mile enrollment Berlin, Germany &#8211;ESMO AI &amp; Digital Oncology Congress 2025 &#8211; November 12, 2025 &#8211; Massive Bio today announced Reticulum Nexus,...","protected":false},"author":11,"featured_media":40933,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55],"tags":[],"class_list":["post-40371","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Reticulum Nexus: Multi-Agent Platform by Massive Bio<\/title>\n<meta name=\"description\" content=\"Massive Bio Announces Reticulum Nexus - an AI-Driven Multi\u2011Agent Platform orchestrating the end-to-end patient journey.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/massivebio.com\/massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Massive Bio Announces Reticulum Nexus - an AI-Driven Multi Agent Platform orchestrating the end-to-end patient journey %\" \/>\n<meta property=\"og:description\" content=\"Massive Bio Announces Reticulum Nexus - an AI-Driven Multi\u2011Agent Platform orchestrating the end-to-end patient journey.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/massivebio.com\/massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey\/\" \/>\n<meta property=\"og:site_name\" content=\"Massive Bio\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-12T10:21:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-14T07:42:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/11\/ReticulumNexus-PR-3.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"767\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Sinan Gul\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:site\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sinan Gul\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Reticulum Nexus: Multi-Agent Platform by Massive Bio","description":"Massive Bio Announces Reticulum Nexus - an AI-Driven Multi\u2011Agent Platform orchestrating the end-to-end patient journey.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/massivebio.com\/massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey\/","og_locale":"en_US","og_type":"article","og_title":"Massive Bio Announces Reticulum Nexus - an AI-Driven Multi Agent Platform orchestrating the end-to-end patient journey %","og_description":"Massive Bio Announces Reticulum Nexus - an AI-Driven Multi\u2011Agent Platform orchestrating the end-to-end patient journey.","og_url":"https:\/\/massivebio.com\/massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey\/","og_site_name":"Massive Bio","article_publisher":"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","article_published_time":"2025-11-12T10:21:56+00:00","article_modified_time":"2025-11-14T07:42:23+00:00","og_image":[{"width":1024,"height":767,"url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/11\/ReticulumNexus-PR-3.webp","type":"image\/webp"}],"author":"Sinan Gul","twitter_card":"summary_large_image","twitter_creator":"@MassiveBio","twitter_site":"@MassiveBio","twitter_misc":{"Written by":"Sinan Gul","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/massivebio.com\/massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey\/#article","isPartOf":{"@id":"https:\/\/massivebio.com\/massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey\/"},"author":{"name":"Sinan Gul","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6"},"headline":"Massive Bio Announces Reticulum Nexus &#8211; an AI-Driven Multi Agent Platform orchestrating the end-to-end patient journey","datePublished":"2025-11-12T10:21:56+00:00","dateModified":"2025-11-14T07:42:23+00:00","mainEntityOfPage":{"@id":"https:\/\/massivebio.com\/massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey\/"},"wordCount":932,"commentCount":4,"publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"image":{"@id":"https:\/\/massivebio.com\/massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/11\/ReticulumNexus-PR-3.webp","articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/massivebio.com\/massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/massivebio.com\/massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey\/","url":"https:\/\/massivebio.com\/massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey\/","name":"Reticulum Nexus: Multi-Agent Platform by Massive Bio","isPartOf":{"@id":"https:\/\/massivebio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/massivebio.com\/massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey\/#primaryimage"},"image":{"@id":"https:\/\/massivebio.com\/massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/11\/ReticulumNexus-PR-3.webp","datePublished":"2025-11-12T10:21:56+00:00","dateModified":"2025-11-14T07:42:23+00:00","description":"Massive Bio Announces Reticulum Nexus - an AI-Driven Multi\u2011Agent Platform orchestrating the end-to-end patient journey.","breadcrumb":{"@id":"https:\/\/massivebio.com\/massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/massivebio.com\/massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey\/#primaryimage","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/11\/ReticulumNexus-PR-3.webp","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/11\/ReticulumNexus-PR-3.webp","width":1024,"height":767},{"@type":"BreadcrumbList","@id":"https:\/\/massivebio.com\/massive-bio-launches-reticulum-nexus-the-multi-agent-platform-connecting-the-entire-oncology-journey\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Homepage","item":"https:\/\/massivebio.com\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/massivebio.com\/resources\/news-en\/"},{"@type":"ListItem","position":3,"name":"Massive Bio Announces Reticulum Nexus &#8211; an AI-Driven Multi Agent Platform orchestrating the end-to-end patient journey"}]},{"@type":"WebSite","@id":"https:\/\/massivebio.com\/#website","url":"https:\/\/massivebio.com\/","name":"Cancer Analysis and Clinical Trial Matching","description":"Best Oncology Advisory Services By Cancer Treatment Care Specialists &amp; Tumor Board Experts in America","publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/massivebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/massivebio.com\/#organization","name":"Massive Bio","url":"https:\/\/massivebio.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","width":"1024","height":"1024","caption":"Massive Bio"},"image":{"@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","https:\/\/x.com\/MassiveBio","https:\/\/instagram.com\/massive_bio\/","https:\/\/tiktok.com\/@massivebio","https:\/\/youtube.com\/massivebio"],"email":"support@massivebio.com","legalName":"Massive Bio"},{"@type":"Person","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6","name":"Sinan Gul"}]}},"_links":{"self":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/40371","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/comments?post=40371"}],"version-history":[{"count":8,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/40371\/revisions"}],"predecessor-version":[{"id":40942,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/40371\/revisions\/40942"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media\/40933"}],"wp:attachment":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media?parent=40371"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/categories?post=40371"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/tags?post=40371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}